RV

Rajiv Vijayraj Deshpande

Active Director Director DIN 08726233
DIN 08726233 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Rajiv Vijayraj Deshpande

Data last updated:

Rajiv Vijayraj Deshpande is a Director at Elixa Medicaments Private Limited (since 2020). The company operates in Pharma. Elixa Medicaments Private Limited reported revenue of ₹24.5 Lakh (FY 2022).

DIN 08726233
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2020
Oldest Company Age 9 yrs
Largest company Elixa Medicaments Private Limited · ₹24.5 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elixa Medicaments Private Limited U33309PN2017PTC172931
Director18 Mar 20202017₹24.5 Lakh (FY 2022)Active

Board colleagues of Rajiv Vijayraj Deshpande

NameDINCompanyDesignation
Rashmi Rajiv Deshpande07932929Elixa Medicaments Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elixa Medicaments Private Limited
Premium access

Shareholding and investment profile for Rajiv Vijayraj Deshpande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Vijayraj Deshpande

Rajiv Vijayraj Deshpande currently holds 1 directorship: Elixa Medicaments Private Limited (Director, since 18 Mar 2020, revenue ₹24.5 Lakh (FY 2022)).

Rajiv Vijayraj Deshpande was first appointed on 18 Mar 2020 as Director at Elixa Medicaments Private Limited.

The current boards of Rajiv Vijayraj Deshpande's companies include Rashmi Rajiv Deshpande (Elixa Medicaments Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available